333 related articles for article (PubMed ID: 26891837)
21. Trypanothione biosynthesis in Leishmania major.
Oza SL; Shaw MP; Wyllie S; Fairlamb AH
Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
[TBL] [Abstract][Full Text] [Related]
22. Properties of trypanothione synthetase from Trypanosoma brucei.
Oza SL; Ariyanayagam MR; Aitcheson N; Fairlamb AH
Mol Biochem Parasitol; 2003 Sep; 131(1):25-33. PubMed ID: 12967709
[TBL] [Abstract][Full Text] [Related]
23. A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi.
Miranda CG; Solana ME; Curto MLA; Lammel EM; Schijman AG; Alba Soto CD
Acta Trop; 2015 Dec; 152():8-16. PubMed ID: 26272680
[TBL] [Abstract][Full Text] [Related]
24. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
Maya JD; Rodríguez A; Pino L; Pabón A; Ferreira J; Pavani M; Repetto Y; Morello A
Biol Res; 2004; 37(1):61-9. PubMed ID: 15174306
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
[TBL] [Abstract][Full Text] [Related]
26. Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake.
Alberca LN; Sbaraglini ML; Morales JF; Dietrich R; Ruiz MD; Pino Martínez AM; Miranda CG; Fraccaroli L; Alba Soto CD; Carrillo C; Palestro PH; Talevi A
Front Cell Infect Microbiol; 2018; 8():173. PubMed ID: 29888213
[TBL] [Abstract][Full Text] [Related]
27. N,N'-thiophene-substituted polyamine analogs inhibit mammalian host cell invasion and intracellular multiplication of Trypanosoma cruzi.
Majumder S; Kierszenbaum F
Mol Biochem Parasitol; 1993 Aug; 60(2):231-9. PubMed ID: 8232414
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis.
Ravaschino EL; Docampo R; Rodriguez JB
J Med Chem; 2006 Jan; 49(1):426-35. PubMed ID: 16392828
[TBL] [Abstract][Full Text] [Related]
29. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
30. Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi.
Vázquez C; Mejia-Tlachi M; González-Chávez Z; Silva A; Rodríguez-Zavala JS; Moreno-Sánchez R; Saavedra E
FEBS Lett; 2017 Dec; 591(23):3881-3894. PubMed ID: 29127710
[TBL] [Abstract][Full Text] [Related]
31. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
32. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
[TBL] [Abstract][Full Text] [Related]
33. Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi.
Reigada C; Valera-Vera EA; Sayé M; Errasti AE; Avila CC; Miranda MR; Pereira CA
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005472. PubMed ID: 28306713
[TBL] [Abstract][Full Text] [Related]
34. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
[TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
[TBL] [Abstract][Full Text] [Related]
36. The ubiquinone synthesis pathway is a promising drug target for Chagas disease.
Nara T; Nakagawa Y; Tsuganezawa K; Yuki H; Sekimata K; Koyama H; Ogawa N; Honma T; Shirouzu M; Fukami T; Matsuo Y; Inaoka DK; Kita K; Tanaka A
PLoS One; 2021; 16(2):e0243855. PubMed ID: 33539347
[TBL] [Abstract][Full Text] [Related]
37. Polyamine-trypanothione pathway: an update.
Ilari A; Fiorillo A; Genovese I; Colotti G
Future Med Chem; 2017 Jan; 9(1):61-77. PubMed ID: 27957878
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives.
Maya JD; Bollo S; Nuñez-Vergara LJ; Squella JA; Repetto Y; Morello A; Périé J; Chauvière G
Biochem Pharmacol; 2003 Mar; 65(6):999-1006. PubMed ID: 12623132
[TBL] [Abstract][Full Text] [Related]
39. Amino Acid and Polyamine Membrane Transporters in Trypanosoma cruzi: Biological Function and Evaluation as Drug Targets.
Sayé M; Reigada C; Gauna L; Valera-Vera EA; Pereira CA; Miranda MR
Curr Med Chem; 2019; 26(36):6636-6651. PubMed ID: 31218951
[TBL] [Abstract][Full Text] [Related]
40. Ensemble learning application to discover new trypanothione synthetase inhibitors.
Alice JI; Bellera CL; Benítez D; Comini MA; Duchowicz PR; Talevi A
Mol Divers; 2021 Aug; 25(3):1361-1373. PubMed ID: 34264440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
